Govt To Soon Approve J&J's Single Dose COVID Jabs At Reasonable Price

India’s principal scientific advisor and co-chair of COVID-19 vaccine task force, K Vijay Raghavan has expected that Centre will soon approve the Johnson and Johnson’s COVID vaccine. Assuring that the pricing and availability will be made transparent, Raghavan hoped the vaccine’s capacity to increases exponentially as Centre looks to boost manufacturing and export of vaccines. J&J recently applied to conduct phase-III clinical trials of its single dose COVID vaccine.